Jonathan Violin

Jonathan Violin has an estimated net worth of $13.8 Million. This is based on reported shares across multiple companies, which include Viridian Therapeutics, Inc.\DE, TREVENA INC, Astria Therapeutics, Inc., Dianthus Therapeutics, Inc. /DE/, and GLYCOMIMETICS INC.

2021 was Jonathan Violin's most active year for acquiring shares with 5 total transactions. Jonathan Violin's most active month to acquire stocks was the month of December. 2022 was Jonathan Violin's most active year for disposing of shares, totalling 9 transactions. Jonathan Violin's most active month to dispose stocks was the month of January. 2023 saw Jonathan Violin paying a total of $7,500.00 for 70,600 shares, this is the most they've acquired in one year. In 2023 Jonathan Violin cashed out on 150,000 shares for a total of $3,680,000.00, their largest year based on trade value.